Cancer Biotherapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: CE3BD0070202EN
Market Monitor Global

Abstracts

Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.

This report contains market size and forecasts of Cancer Biotherapy in Global, including the following market information:

Global Cancer Biotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Biotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Biotherapy include Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Biotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Biotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Biotherapy Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Vaccines
• Erythropoietin
• Colony Stimulating Factors
• Interleukins and Interferons

Global Cancer Biotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Biotherapy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Laboratories
• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies
• Others

Global Cancer Biotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Biotherapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Biotherapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Biotherapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Bristol-Myers Squibb
• Celgene
• GlaxoSmithKline
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Biotherapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Biotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER BIOTHERAPY OVERALL MARKET SIZE

2.1 Global Cancer Biotherapy Market Size: 2021 VS 2028
2.2 Global Cancer Biotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Biotherapy Players in Global Market
3.2 Top Global Cancer Biotherapy Companies Ranked by Revenue
3.3 Global Cancer Biotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Biotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biotherapy Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Biotherapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Biotherapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Biotherapy Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Vaccines
  4.1.4 Erythropoietin
  4.1.5 Colony Stimulating Factors
  4.1.6 Interleukins and Interferons
4.2 By Type - Global Cancer Biotherapy Revenue & Forecasts
  4.2.1 By Type - Global Cancer Biotherapy Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Biotherapy Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Biotherapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Biotherapy Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Research and Academic Laboratories
  5.1.5 Pharmaceutical and Biotechnology Companies
  5.1.6 Others
5.2 By Application - Global Cancer Biotherapy Revenue & Forecasts
  5.2.1 By Application - Global Cancer Biotherapy Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Biotherapy Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Biotherapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Biotherapy Market Size, 2021 & 2028
6.2 By Region - Global Cancer Biotherapy Revenue & Forecasts
  6.2.1 By Region - Global Cancer Biotherapy Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Biotherapy Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Biotherapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Biotherapy Revenue, 2017-2028
  6.3.2 US Cancer Biotherapy Market Size, 2017-2028
  6.3.3 Canada Cancer Biotherapy Market Size, 2017-2028
  6.3.4 Mexico Cancer Biotherapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Biotherapy Revenue, 2017-2028
  6.4.2 Germany Cancer Biotherapy Market Size, 2017-2028
  6.4.3 France Cancer Biotherapy Market Size, 2017-2028
  6.4.4 U.K. Cancer Biotherapy Market Size, 2017-2028
  6.4.5 Italy Cancer Biotherapy Market Size, 2017-2028
  6.4.6 Russia Cancer Biotherapy Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Biotherapy Market Size, 2017-2028
  6.4.8 Benelux Cancer Biotherapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Biotherapy Revenue, 2017-2028
  6.5.2 China Cancer Biotherapy Market Size, 2017-2028
  6.5.3 Japan Cancer Biotherapy Market Size, 2017-2028
  6.5.4 South Korea Cancer Biotherapy Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Biotherapy Market Size, 2017-2028
  6.5.6 India Cancer Biotherapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Biotherapy Revenue, 2017-2028
  6.6.2 Brazil Cancer Biotherapy Market Size, 2017-2028
  6.6.3 Argentina Cancer Biotherapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Biotherapy Revenue, 2017-2028
  6.7.2 Turkey Cancer Biotherapy Market Size, 2017-2028
  6.7.3 Israel Cancer Biotherapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Biotherapy Market Size, 2017-2028
  6.7.5 UAE Cancer Biotherapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Cancer Biotherapy Major Product Offerings
  7.1.4 Amgen Cancer Biotherapy Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Cancer Biotherapy Major Product Offerings
  7.2.4 Bristol-Myers Squibb Cancer Biotherapy Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Celgene
  7.3.1 Celgene Corporate Summary
  7.3.2 Celgene Business Overview
  7.3.3 Celgene Cancer Biotherapy Major Product Offerings
  7.3.4 Celgene Cancer Biotherapy Revenue in Global Market (2017-2022)
  7.3.5 Celgene Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Cancer Biotherapy Major Product Offerings
  7.4.4 GlaxoSmithKline Cancer Biotherapy Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Cancer Biotherapy Major Product Offerings
  7.5.4 Eli Lilly Cancer Biotherapy Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Biotherapy Market Opportunities & Trends in Global Market
Table 2. Cancer Biotherapy Market Drivers in Global Market
Table 3. Cancer Biotherapy Market Restraints in Global Market
Table 4. Key Players of Cancer Biotherapy in Global Market
Table 5. Top Cancer Biotherapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Biotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Biotherapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Biotherapy Product Type
Table 9. List of Global Tier 1 Cancer Biotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Biotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Biotherapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Biotherapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Biotherapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Biotherapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Biotherapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Biotherapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Biotherapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Biotherapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Biotherapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Biotherapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Biotherapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Biotherapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Biotherapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Biotherapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Biotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Biotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Biotherapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Biotherapy Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Cancer Biotherapy Product Offerings
Table 32. Amgen Cancer Biotherapy Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Cancer Biotherapy Product Offerings
Table 35. Bristol-Myers Squibb Cancer Biotherapy Revenue (US$, Mn), (2017-2022)
Table 36. Celgene Corporate Summary
Table 37. Celgene Cancer Biotherapy Product Offerings
Table 38. Celgene Cancer Biotherapy Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Cancer Biotherapy Product Offerings
Table 41. GlaxoSmithKline Cancer Biotherapy Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Cancer Biotherapy Product Offerings
Table 44. Eli Lilly Cancer Biotherapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Biotherapy Segment by Type in 2021
Figure 2. Cancer Biotherapy Segment by Application in 2021
Figure 3. Global Cancer Biotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Biotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Biotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biotherapy Revenue in 2021
Figure 8. By Type - Global Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 12. US Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 24. China Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Biotherapy Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Biotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celgene Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)